Biohaven (BHVN) Prepaid Assets (2021 - 2026)
Biohaven (BHVN) posted Prepaid Assets of $34.7 million for Q1 2026, down 26.27% sequentially from $47.0 million in Q4 2025, and up 858.18% YoY from $3.6 million in Q1 2025.
Biohaven (BHVN) Prepaid Assets (2021 - 2026) Analysis & Trends
Biohaven has reported Prepaid Assets for 6 years, with the latest figure at $34.7 million in Q1 2026.
- Quarterly Prepaid Assets rose 858.18% year-over-year to $34.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.7 million (up 858.18% YoY) and the FY2025 annual result came in at $47.0 million, down 4.77% from the prior year.
- Prepaid Assets eased to $34.7 million in Q1 2026 per BHVN's latest filing, from $47.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $61.5 million in Q2 2025 and troughed at $1.2 million in Q3 2024.
- A 5-year average of $28.7 million and a median of $24.7 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 887.51% in 2022, then slumped 96.47% in 2024.
- Over 5 years, Prepaid Assets stood at $20.9 million in 2022, then surged by 68.26% to $35.2 million in 2023, then surged by 40.11% to $49.4 million in 2024, then fell by 4.77% to $47.0 million in 2025, then decreased by 26.27% to $34.7 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $34.7 million, $47.0 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.04 Mn |
| Mar 31, 2026 | 34.67 Mn |
| Dec 31, 2025 | 47.02 Mn |
| Sep 30, 2025 | 8.42 Mn |
| Jun 30, 2025 | 61.49 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Dec 31, 2024 | 49.38 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 59.53 Mn |
| Mar 31, 2024 | 10.68 Mn |
| Dec 31, 2023 | 35.24 Mn |
| Sep 30, 2023 | 33.94 Mn |
| Jun 30, 2023 | 22.28 Mn |
| Mar 31, 2023 | 24.67 Mn |
| Dec 31, 2022 | 20.95 Mn |
| Sep 30, 2022 | 17.91 Mn |
| Dec 31, 2021 | 2.12 Mn |